TY  - JOUR
AU  - Alice Taubes, Alice
AU  - Nova, Phil
AU  - Zalocusky, Kelly A.
AU  - Kosti, Idit
AU  - Bicak, Mesude
AU  - Zilberter, Misha Y.
AU  - Hao, Yanxia
AU  - Yoon, Seo Yeon
AU  - Oskotsky, Tomiko
AU  - Pineda Sanjuan, Silvia
AU  - Bin Chen, Emily A.
AU  - Jones, Aery
AU  - Choudhary, Krishna
AU  - Grone,  Brian
AU  - Balestra, Maureen E.
AU  - Chaudhry, Fayzan
AU  - Paranjpe, Ishan
AU  - De Freitas, Jessica
AU  - Koutsodendris, Nicole
AU  - Chen, Nuo
AU  - Wang, Celine
AU  - William Chang, William
AU  - An, Alice
AU  - Glicksberg, Benjamin S.
AU  - Sirota, Marina
AU  - Huang, Yadong
AU  - Thuault, Sebastien
PY  - 2021
DO  - 10.1038/s43587-021-00122-7
SN  - 2662-8465
UR  - https://hdl.handle.net/20.500.14352/96873
T2  - Nature Aging
AB  - The evident genetic, pathological and clinical heterogeneity of Alzheimer’s disease (AD) poses challenges for traditional drug development. We conducted a computational drug-repurposing screen for drugs to treat apolipoprotein E4 (APOE4)-related AD....
LA  - eng
M2  - 932
PB  - Nature Publishing Group
TI  - Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease
TY  - journal article
VL  - 1
ER  -